Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally represents a ...

A University of the Pacific team has developed a single-dose injection to counter the effects of fentanyl and other opioid overdoses.

A professor and his team at University of the Pacific have developed a single-dose treatment that provides extended ...

A new study led by researchers at University Hospitals Connor Whole Health found that adults with newly diagnosed sciatica ...